Tragic baby boy crushed to death after dad suffers fatal heart attack and collapses on top of him
DOUBLE TRAGEDY Tragic baby boy crushed to death after dad suffers fatal heart attack and collapses on top of him
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
A THREE-MONTH-OLD boy was fatally crushed when his dad suffered a heart attack while cuddling him in bed.
Little Muhammad Nur Daniel Nurul Effendy and dad Nurul Effendy Ibrahim, 35, were found dead at their family home in Malaysia.
Sign up for Scottish Sun
newsletter
Sign up
2
Dad Nurul and baby Muhammad were found dead today
Credit: Newsflash
2
The tragedy has shocked Malaysia
Credit: Newsflash
Dad Nurul was found unconscious by his wife, Azura, with their baby lying under his arm on Thursday.
At first, Azura thought there had been a gas leak in the family's home in Melaka, in southern Malaysia, local media reports.
She told media: "I knew something was wrong even though there was no blood.
"My husband was unconscious and our baby, who was still breathing at that time, was pinned under his arm. However, our baby looked very weak and pale.'
Read more world news
TOWERING DEFIANCE Stubborn homeowner builds PYRAMID after developers demolished village
The tot, who had turned blue from the lack of oxygen, was rushed to hospital but died while receiving treatment.
Relatives said that the night before, Nurul had complained of chest pains.
The couple had reportedly waited 15 years for Muhammad, their third child.
Cases of infants dying from asphyxiation while sleeping or cuddling with a parent are sadly not unique.
Unintentional suffocation is the leading cause of injury death among infants under the age of one in the US, according to the National Institutes of Health.
It is not recommended to co-sleep with babies, especially if they were born premature or with a low birth weight, as per guidance from the NHS.
Falling asleep with a baby on a sofa or chair is said to greatly increase the risk of sudden infant death syndrome (SIDS).
Brit backpacker, 25, found dead in Malaysia one week after vanishing as his phone went dead & family flew out to find him
It comes as missing Brit backpacker Jordan Johnson-Doyle was found dead in Malaysia in early June.
Jordan, 25, from Southport, was last seen at a bar in capital Kuala Lumpur but then vanished - sparking a frantic search from family and police.
Jordan had been travelling around south-east Asia while working remotely for an American software company.
Malaysian police confirmed on June 5 that a body was found at the base of a lift shaft, and had been identified as Jordan.
Kuala Lumpur police chief Rusdi Mohd Isa said the force had "received information that a man was found lying on his back in the lift [shaft] on the ground floor of a construction site".
He added that the post-mortem examination revealed "the cause of death was a chest injury sustained from a fall from height".
The death is not being treated as suspicious.
A FCDO spokesperson said at the time that the Foreign Office was "supporting the family of a British man who died in Malaysia".
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
4 hours ago
- The Independent
NIH cuts spotlight a hidden crisis facing patients with experimental brain implants
Carol Seeger finally escaped her debilitating depression with an experimental treatment that placed electrodes in her brain and a pacemaker-like device in her chest. But when its batteries stopped working, insurance wouldn't pay to fix the problem and she sank back into a dangerous darkness. She worried for her life, asking herself: 'Why am I putting myself through this?' Seeger's predicament highlights a growing problem for hundreds of people with experimental neural implants, including those for depression, quadriplegia and other conditions. Although these patients take big risks to advance science, there's no guarantee that their devices will be maintained — particularly after they finish participating in clinical trials — and no mechanism requiring companies or insurers to do so. A research project led by Gabriel Lázaro-Muñoz, a Harvard University scientist, aimed to change that by creating partnerships between players in the burgeoning implant field to overcome barriers to device access and follow-up care. But the cancellation of hundreds of National Institutes of Health grants by the Trump administration this year left the project in limbo, dimming hope for Seeger and others like her who wonder what will happen to their health and progress. An ethical quagmire Unlike medications, implanted devices often require parts, maintenance, batteries and surgeries when changes are needed. Insurance typically covers such expenses for federally approved devices considered medically necessary, but not experimental ones. A procedure to replace a battery alone can cost more than $15,000 without insurance, Lázaro-Muñoz said. While companies stand to profit from research, 'there's really nothing that helps ensure that device manufacturers have to provide any of these parts or cover any kind of maintenance,' said Lázaro-Muñoz. Some companies also move on to newer versions of devices or abandon the research altogether, which can leave patients in an uncertain place. Medtronic, the company that made the deep brain stimulation, or DBS, technology Seeger used, said in a statement that every study is different and that the company puts patient safety first when considering care after studies end. People consider various possibilities when they join a clinical trial. The Food and Drug Administration requires the informed consent process to include a description of 'reasonably foreseeable risks and discomforts to the participant,' a spokesperson said. However, the FDA doesn't require trial plans to include procedures for long-term device follow-up and maintenance, although the spokesperson stated that the agency has requested those in the past. While some informed consent forms say devices will be removed at a study's end, Lázaro-Muñoz said removal is ethically problematic when a device is helping a patient. Plus, he said, some trial participants told him and his colleagues that they didn't remember everything discussed during the consent process, partly because they were so focused on getting better. Brandy Ellis, a 49-year-old in Boynton Beach, Florida, said she was desperate for healing when she joined a trial testing the same treatment Seeger got, which delivers an electrical current into the brain to treat severe depression. She was willing to sign whatever forms were necessary to get help after nothing else had worked. 'I was facing death,' she said. 'So it was most definitely consent at the barrel of a gun, which is true for a lot of people who are in a terminal condition.' Patients risk losing a treatment of last resort Ellis and Seeger, 64, both turned to DBS as a last resort after trying many approved medications and treatments. 'I got in the trial fully expecting it not to work because nothing else had. So I was kind of surprised when it did,' said Ellis, whose device was implanted in 2011 at Emory University in Atlanta. 'I am celebrating every single milestone because I'm like: This is all bonus life for me.' She's now on her third battery. She needed surgery to replace two single-use ones, and the one she has now is rechargeable. She's lucky her insurance has covered the procedures, she said, but she worries it may not in the future. 'I can't count on any coverage because there's nothing that says even though I've had this and it works, that it has to be covered under my commercial or any other insurance,' said Ellis, who advocates for other former trial participants. Even if companies still make replacement parts for older devices, she added, 'availability and accessibility are entirely different things,' given most people can't afford continued care without insurance coverage. Seeger, whose device was implanted in 2012 at Emory, said she went without a working device for around four months when the insurance coverage her wife's job at Emory provided wouldn't pay for battery replacement surgery. Neither would Medicare, which generally only covers DBS for FDA-approved uses. With her research team at Emory advocating for her, Seeger ultimately got financial help from the hospital's indigent care program and paid a few thousand dollars out of pocket. She now has a rechargeable battery, and the device has been working well. But at any point, she said, that could change. Federal cuts stall solutions Lázaro-Muñoz hoped his work would protect people like Seeger and Ellis. 'We should do whatever we can as a society to be able to help them maintain their health,' he said. Lázaro-Muñoz's project received about $987,800 from the National Institute of Mental Health in the 2023 and 2024 fiscal years and was already underway when he was notified of the NIH funding cut in May. He declined to answer questions about it. Ellis said any delay in addressing the thorny issues around experimental brain devices hurts patients. Planning at the beginning of a clinical trial about how to continue treatment and maintain devices, she said, would be much better than depending on the kindness of researchers and the whims of insurers. 'If this turns off, I get sick again. Like, I'm not cured,' she said. 'This is a treatment that absolutely works, but only as long as I've got a working device.' ____ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Reuters
4 hours ago
- Reuters
Medical group urges Kennedy not to fire US care task force
WASHINGTON, July 27 (Reuters) - U.S. Health Secretary Robert F. Kennedy Jr. should not fire an advisory panel that determines what cancer screenings and other preventive health measures insurers must cover, an influential doctors' group said on Sunday. The American Medical Association sent Kennedy a letter on Sunday expressing its concern after the Wall Street Journal reported on Friday he planned to remove all of the panel's members. The Department of Health and Human Services said Kennedy had not yet made a decision. "On behalf of the physician and medical student members of the American Medical Association, I am writing to express our deep concern with the recent reports of your intention to remove all of the members of the United States Preventive Services Task Force," John Whyte, the AMA chief executive officer, wrote. HHS did not immediately respond to a request for comment on the AMA letter. The Wall Street Journal, citing people familiar with the matter, had said Kennedy planned to dismiss all 16 panel members in what would be the latest in a series of far-reaching actions by Kennedy, a long-time vaccine skeptic, to reshape U.S. regulation of vaccines, food and medicine. In June he fired all 17 members of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices, a panel of vaccine experts, replacing them with seven handpicked members, including known vaccine skeptics. "USPSTF members play in weighing the benefits and harms of preventive services such as screenings, behavioral counseling, and preventive medications, and making evidence-based recommendations for implementation in primary care settings," the AMA letter said. "We urge you to keep the previously appointed USPSTF members and continue the task force's regular meeting schedule to ensure recommendations are put forth, updated, and disseminated without delay," it said. The AMA passed an emergency resolution in June asking for a Senate investigation into the firing of ACIP members. The group also sent Kennedy a letter at the time calling for an immediate reversal of the changes.
Scottish Sun
9 hours ago
- Scottish Sun
Inside China's sick plot to build empire of ‘organ harvesting centres' in five years… with ‘donors' already lined up
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) CHINA'S regime is significantly expanding its empire of organ harvesting centres in a twisted bid to make money, experts say. A plot to build six new sites in Xinjiang Uyghur by 2030 has stoked fears of forced organ removal - given staggeringly low donation rates in the region. Sign up for Scottish Sun newsletter Sign up 4 An organ removal operation takes place in China Credit: supplied 4 A hospital in Urumqi in Xinjiang, China Credit: Supplied China's organ trade is already estimated to have a market value of $1 billion per year - which the Communist government wants to swell. A liver transplant, for example, can cost around £118,000 ($160k) in China - but with a much shorter waiting time compared to the rest of the world. This draws in not only recipients from inside the sprawling nation, but also unsuspecting international visitors who travel there for a transplant. China's regime has long been accused of orchestrating a non-consensual organ harvesting campaign against persecuted minorities. Prisoners are known to be killed specifically for the extraction of their organs. Experts say the primary victims of forced organ harvesting are those who follow Buddhist qigong and meditation practice of Falun Gong. They also believe that incarcerated Uyghurs fall victim - and new facilities are planned to open in their autonomous region of Xinjiang. At least six transplant institutions are tipped to open in the next five years, which campaigners say is hugely disproportionate to Xinjiang's low organ donation rate. Xinjiang is understood to have an organ donation rate of just 0.69 per cent per million people - significantly below the national average of 4.66 per cent. It has raised questions among experts who fear it could be part of a sickening plot to use detained Uyghurs as a living organ "donation" bank. Ughur detainees have reported forced blood tests, ultrasounds and organ-focused medical scans while in custody. Insiders say such procedures are consistent with chilling organ compatibility testing. Wendy Rogers, Chair of the International Advisory Board of the International Coalition to End Transplant Abuse in China (ETAC), told the Sun: "The guise is that all the organs will come from voluntary donations. "But this is implausible given the reported rate of just 0.69 donors per million people in Xinjiang. "This massive expansion in Xinjiang - a region already under scrutiny for systematic repression - raises deeply troubling questions about where the organs will come from. 'There is simply no justification for such growth in transplant capacity given the region's official organ donation rate, which is far below the national average.' 'Plot to kill survivor' by Katie Davis, Chief Foreign Reporter (Digital) THE first known survivor of China's brutal organ harvesting scheme says the regime is plotting to kill him and stage his death as suicide. Cheng Peiming told how Xi Jinping's communist party is on a mission to silence him after he helped expose its organ harvesting plot. He revealed how he was tortured and had parts of his liver and lung removed by Xi's stooges after being imprisoned for practicing the Falun Gong religion. Leaked insider information reveals China's security services and high-level Chinese Communist Party (CCP) leaders have taken notice - and have unleashed a plot to try and discredit, or even kill, Cheng. The CCP has said to "kill him directly and make it look like a suicide" if needed, according to bombshell information from an internal source. Cheng has faced several suspicious threats to his physical safety, including an early hours break-in of his home in New York in November. The intruder forced open the bolt on the garage door, left two doors open and left deep tyre marks in his backyard. Cheng believes the break-in was an attempt to intimidate and silence him after a series of other attacks. READ MORE HERE Up to 100,000 organ transplants are estimated to be carried out in China every year - with huge swathes harvested without consent. New facilities - which will triple the number in the region from three to nine - will offer heart, lung, liver, kidney and pancreas/ small intestine transplants. The Chinese government claimed back in 2015 that it had stopped using organs from executed prisoners - but no legal reforms were coupled with the announcement. Experts say sourcing organs from prisoners was never explicitly banned either. Rogers, who is a professor of Clinical Ethics, added: "We know that China is expanding its transplant capacity in Xinjiang, despite the relatively small population, low voluntary organ donation rates and existing capacity. "This doesn't make sense unless the hospitals involved are confident that there will be a steady supply of organs for transplantation. "In the absence of any other organ source, we believe that the organs will come from Uyghur and other minorities who are incarcerated in camps Xinjiang, and killed for their organs. "Organ transplantation generates a lot of income, so the motive may be financial." It comes after The Sun reported how China's government uses cash bribes and death threats in a warped intimidation crusade against critics. Leaked documents exposed a shocking escalation of attacks on whistleblowers and victims of a forced organ harvesting campaign orchestrated by the regime. Whistleblowers who attended a secret Chinese Communist Party (CCP) meeting have revealed information from inside Xi Jinping's government. This and a dossier of evidence laid bare a multi-pronged scheme spearheaded by Xi to silence members of Falun Gong and other groups vocal about China's severe persecution. 4 Cheng Peiming, pictured showing a huge scar from forced surgery, has been threatened Credit: International Coalition to End Transplant Abuse in China
